Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Advicenne
Advicenne
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Sibnayal
Hydrogen
2021-04-30
Renal tubular acidosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Nepidermin
primary myelofibrosis
,
healthy volunteers/patients
,
uterine cervical neoplasms
,
rectal neoplasms
,
cholangiocarcinoma
,
folliculitis
,
glioma
,
central nervous system neoplasms
,
nervous system neoplasms
,
colorectal neoplasms
,
lymphoma
,
stomach neoplasms
,
carcinoma
,
neoplasms
,
ovarian neoplasms
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
triple negative breast neoplasms
,
leukemia
,
hepatocellular carcinoma
,
liver neoplasms
,
melanoma
,
non-hodgkin lymphoma
,
ulcerative colitis
,
b-cell chronic lymphocytic leukemia
,
small cell lung carcinoma
,
neoplasm metastasis
,
hemophilia a
,
macular edema
,
urinary bladder neoplasms
,
lupus nephritis
,
nephritis
,
lymphoid leukemia
,
ductal carcinoma breast
,
macular degeneration
,
edema
,
renal cell carcinoma
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
glioblastoma
,
head and neck neoplasms
,
ovarian epithelial carcinoma
,
asthma
,
sclerosis
,
mucinous adenocarcinoma
,
inflammatory breast neoplasms
,
paroxysmal hemoglobinuria
,
pancreatic neoplasms
,
colitis
,
ulcer
,
skin diseases
,
neoplasms by site
,
breast diseases
,
urologic neoplasms
,
prostatic neoplasms
,
transitional cell carcinoma
,
colonic neoplasms
,
nasal polyps
,
hemoglobinuria
,
follicular lymphoma
,
systemic scleroderma
,
diffuse scleroderma
,
retinal vein occlusion
,
crohn disease
,
schizophrenia
,
atypical hemolytic uremic syndrome
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
geographic atrophy
,
atrophy
,
systemic lupus erythematosus
,
nephrotic syndrome
,
lipoid nephrosis
,
brain neoplasms
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
esophageal neoplasms
,
castration-resistant prostatic neoplasms
,
retinal diseases
,
diabetic retinopathy
,
vision disorders
,
eye diseases
,
thyroid neoplasms
,
neuroendocrine carcinoma
,
papillary thyroid cancer
,
thyroid diseases
,
disease progression
,
recurrence
,
endometrioid carcinoma
,
arteritis
,
giant cell arteritis
,
polymyalgia rheumatica
,
type 2 diabetes mellitus
,
diabetes mellitus
,
kidney diseases
,
membranous glomerulonephritis
,
multiple sclerosis
,
chronic progressive multiple sclerosis
,
ankylosing spondylitis
,
spondylarthritis
,
spondylitis
,
myeloid leukemia acute
,
myeloid leukemia
,
alzheimer disease
,
coronary disease
,
acute coronary syndrome
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
relapsing-remitting multiple sclerosis
,
guillain-barre syndrome
,
syndrome
,
nephrosis
,
autoimmune diseases of the nervous system
,
hashimoto disease
,
encephalitis
,
partial epilepsies
,
bcr-abl positive chronic myelogenous leukemia
,
circulating neoplastic cells
,
disability evaluation
,
cognition disorders
,
cytomegalovirus infections
,
anemia
,
hemolysis
,
hemolytic anemia autoimmune
,
focal segmental glomerulosclerosis
,
endometrial neoplasms
,
covid-19
,
graft rejection
,
retinal neovascularization
,
human influenza
,
type 3 von willebrand disease
,
breast neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma
,
adenocarcinoma of lung
,
osteoporosis
,
postmenopausal osteoporosis
Sulthiame
epilepsy
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use